Jul 10, 2014

CardioCell begins phase IIa trial using itMSC therapy for chronic heart failure

CardioCell, a Stemedica Cell Technologies subsidiary that creates allogeneic stem-cell therapies for cardiovascular indications, has started its phase IIa clinical trial for chronic heart failure (HF) patients with non-ischemic cardiomyopathy. READ FULL ARTICLE